Sintim team develops compound to treat drug-resistant acute myeloid leukemia
Purdue researchers have developed a patent-pending compound designed to treat drug-resistant acute myeloid leukemia. PICR member Herman Sintim leads the team.
Research
Give Now
Events
Tyler Trent Pediatric Cancer Research Center
In creating the Tyler Trent Pediatric Cancer Research Center, the Purdue Institute for Cancer Research (PICR) brings together deep strengths in multiple research fields to fight pediatric cancers and to beat osteosarcoma, the rare bone cancer that took the life of beloved Purdue alumnus Tyler Trent.
Tyler’s parents, Tony and Kelly Trent, lead the way with their gift of $100,000 to continue the fight against cancer that Tyler began. To join in the fight, you can donate here to the center’s life-sustaining research.
